News | August 03, 2024
Eris Lifesciences posts Q1 FY25 at Rs. 89 Cr
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
The Unit has been issued GMP Certification from ANVISA-Brazil
This plant is located at Baddi, Himachal Pradesh spread over an area of 2.85 acres
The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Both organisations enter into a long- term collaboration to expand patient access in India
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Subscribe To Our Newsletter & Stay Updated
